1. 30: STRONG IMPACT OF SARCOPENIA AS A RISK FACTOR OF SURVIVAL IN RESECTED GASTRIC CANCER PATIENTS: FIRST REPORT FROM AN ITALIAN CANCER CENTER. (23rd April 2022) Authors: Ricciardolo, A A; De Ruvo, N; Prampolini, F; Pecchi, A; Missori, G; Sorrentino, L; Rossi, E G; Fenocchi, S; Salati, M; Spallanzani, A; Cautero, N; Serra, F; Gelmini, R Journal: Diseases of the esophagus Issue: Volume 35(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 588PThe role of primary tumour location in the recurrence rate of metachronous metastasis of colon cancer. (23rd October 2018) Authors: Rimini, M; Bardasi, C; Gelsomino, F; Andrikou, K; Santini, C; Orsi, G; Salati, M; Riggi, M L; Pipitone, S; Cascinu, S; Spallanzani, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 673PDNab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial. (1st October 2019) Authors: Cascinu, S; Berardi, R; Bianco, R; Bilancia, D; Zaniboni, A; Ferrari, D; Mosconi, S; Spallanzani, A; Cavanna, L; Leo, S; Negri, F; Beretta, G D; Sobrero, A; Banzi, M; Morabito, A; Bittoni, A; Marciano, R; Ferrara, D; Noventa, S; Piccirillo, M C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 770PA novel immune-inflammatory score to predict survival in patients (pts) with advanced biliary tract cancer (ABTC) receiving first-line chemotherapy (1-line cht). (23rd October 2018) Authors: Salati, M; Caputo, F; Spallanzani, A; Rimini, M; Gelsomino, F; Andrikou, K; Cascinu, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Brain metastases: an overview. (January 2015) Authors: Bertolini, F; Spallanzani, A; Fontana, A; Depenni, R; Luppi, G Journal: CNS oncology Issue: Volume 4:Number 1(2015) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Brain metastases: an overview. (January 2015) Authors: Bertolini, F; Spallanzani, A; Fontana, A; Depenni, R; Luppi, G Journal: CNS oncology Issue: Volume 4:Number 1(2015) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P-052Is there an optimal choice in refractory colorectal cancer? A network meta-analysis. (2nd July 2019) Authors: Casadei Gardini, A; Gelsomino, F; Spallanzani, A; Tamburini, E; Scartozzi, M; Cascinu, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-275Immune-inflammatory and clinicopathologic prognostic factors in a Western cohort of resected gastric cancers (GCs). (2nd July 2019) Authors: Salati, M; Pipitone, S; Rimini, M; Gelsomino, F; Gardini, A Casadei; Andrikou, K; Schipilliti, F; Cortesi, G; Cassanelli, L; Caffari, E; Serra, F; Ricciardolo, A; Ruvo, N De; Gelmini, R; Cascinu, S; Spallanzani, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗